Skip to main content
Glama

Wikiquote

by io.github.pipeworx-io

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. First observed

TDQS

A4.6/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Beyond the readOnly/idempotent annotations, the description reveals important behavior: it cascades through multiple endpoints, asserts nothing on ambiguous matches and returns figi_candidates, reports unresolved identifiers explicitly instead of omitting them, and degrades gracefully when GLEIF/OpenFIGI are unavailable. This is substantive behavioral disclosure, not a restatement of annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The material is front-loaded with examples and the 'Use FIRST' directive, and it is structured by SUPPORTED TYPES. It is long and dense with parentheticals, but nearly every sentence carries an edge-case or behavioral fact needed to use a complex resolver correctly.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With no output schema, the description still explains what a caller should expect: labels and sources on identifiers, an unresolved field, figi_candidates for ambiguous matches, and degradation behavior. For both supported types it states the inputs and returned identifier concepts, which is enough to invoke and interpret the tool correctly.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is already 100%, so the baseline is 3. The description adds value by expanding accepted company inputs to include ISIN (not listed in the value schema), clarifying that bond lookups require the issuer name only, and mapping drug input to RxNorm concepts. This goes beyond the schema's basic type/value descriptions.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description opens with concrete natural-language queries and states the function precisely: resolve a user-spoken name to canonical/official identifiers other tools require as input. It names the supported entity types (company, drug) and the specific identifier sets returned, making it clearly distinct from generic search or entity-profile tools.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

It gives an explicit trigger: 'Use FIRST whenever you have a name but need an ID.' It also notes that the tool replaces multiple manual lookups and covers cases like non-US issuers where EDGAR cannot reach. It does not name sibling alternatives or state when not to use it, so it stops short of full exclusion guidance.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Wikiquote toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

B3/5.0
Disambiguation2/5

The tool set mixes four Wikiquote tools with 31 unrelated Pipeworx/Polymarket tools, creating a confusing dual identity. Within the research tooling, ask_pipeworx, ask_pipeworx_beta, and ask_pipeworx_grounded are near-synonyms, and polymarket_arbitrage, polymarket_edges, polymarket_edge_tracker, polymarket_fill_risk overlap heavily, making selection ambiguous.

Naming Consistency3/5

All names are snake_case, but patterns vary: some are verb-first (ask_pipeworx, compare_entities, resolve_entity), some noun-first (entity_profile, polymarket_arbitrage, quote_of_the_day), and several are bare verbs or nouns (search, summary, remember, quotes). Prefix groups like ask_pipeworx* and polymarket_* are consistent, but the overall convention is mixed.

Tool Count2/5

35 tools is excessive for a server named Wikiquote, as only 4 tools (quote_of_the_day, quotes, search, summary) actually serve that domain. The remaining 31 form an unrelated general research and prediction-market toolkit, making the set feel bloated and off-scope for its stated name.

Completeness1/5

As a Wikiquote server, the surface is severely incomplete: there is no random quote, page listing, author/topic browsing, or any write/update operations, and the few quotation tools are buried among unrelated functionality. The unrelated research tools may be internally rich, but they do not address the server's stated purpose.

Resources